Systematic review of randomised clinical trials and observational studies for patients with RAS wild-type or BRAF-mutant metastatic and/or unresectable colorectal cancer
Author:
Funder
Pierre Fabre Médicament SAS
Publisher
Elsevier BV
Subject
Oncology,Hematology
Reference72 articles.
1. Consequences of a high incidence of microsatellite instability and BRAF-mutated tumors: a population-based cohort of metastatic colorectal cancer patients;Aasebo;Cancer Med.,2019
2. EGFR gene copy number predicts response to anti-EGFR treatment in RAS wild type and RAS/BRAF/PIK3CA wild type metastatic colorectal cancer;Algars;Int. J. Cancer,2017
3. Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer;Amado;J. Clin. Oncol.,2008
4. BRAF V600E mutant colorectal cancer subtypes based on gene expression;Barras;Clin. Cancer Res.,2017
5. ERK inhibitor LY3214996 targets ERK pathway-driven Cancers: A therapeutic approach toward precision medicine;Bhagwat;Mol. Cancer Ther.,2020
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Clinical research progress on BRAF V600E-mutant advanced colorectal cancer;Journal of Cancer Research and Clinical Oncology;2023-08-28
2. European expert panel consensus on the clinical management of BRAF-mutant metastatic colorectal cancer;Cancer Treatment Reviews;2023-04
3. Clinical outcomes of neoadjuvant chemotherapy for resectable colorectal liver metastasis with intermediate risk of postoperative recurrence: A multi‐institutional retrospective study;Annals of Gastroenterological Surgery;2022-10-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3